Scientific Industries (OTCQB:SCND) Announces 15% Increase in Torbal Division Sales

BOHEMIA, N.Y. — November 20, 2025 — Leads & Copy — Scientific Industries, Inc. (OTCQB: SCND) has released its financial results for the three and nine months ending September 30, 2025, and has announced the launch of a new AI-enabled feature for its VIVID WORKSTATION, according to a press release issued November 19, 2025.

The company, a developer of digitally simplified bioprocessing solutions and vision-based pill counters, reported a net revenue of $1.4 million for the third quarter, up from $1.3 million in the prior-year period. Gross profit for the quarter was $0.6 million, compared to $0.7 million in the prior year, with gross margin at 45.5% versus 51.0% in the previous year. As of September 30, 2025, Scientific Industries held $8.3 million in cash, cash equivalents, and investments.

For the nine months ending September 30, 2025, net revenues totaled $3,427,100, a decrease of $87,500, or 2.5%, from $3,514,600 for the nine months ended September 30, 2024.

Helena Santos, Chief Executive Officer of Scientific Industries, said that the divestiture of the Genie brand portfolio has sharpened the company’s focus on its high-growth segments, including its pill counting business. The introduction of AI-driven capabilities in the VIVID WORKSTATION, she said, is redefining innovation in pharmacy automation, strengthening compliance and accountability, and delivering significant cost efficiencies for customers.

John Moore, Chairman, noted that Scientific Bioprocessing continues to innovate with the introduction of the world’s first dissolved oxygen sensor designed for baffled flasks.

“Nine out of ten pilot testers were surprised to discover that their cultures were severely oxygen-limited, meaning they were not producing their Gene of Interest (GOI) as expected,” said Moore. “These insights have led to major new customer wins, seamless workflow integrations, and repeat orders.”

According to the press release, key 2025 third quarter financial highlights include:

  • Launched an innovative prescription label documentation and verification feature for the VIVID WORKSTATION, harnessing AI technology
  • Achieved a 27% year-over-year sales increase for VIVID products
  • Torbal Division sales up 15% year-over-year
  • DOTS MPS Platform augmented with single use nanoparticles for baffled flasks

Financial results reflect a gain on sale of $5,263,400 from the Genie Division sale on August 7, 2025, to Ohaus Corporation’s affiliate, Troemner, LLC.

The company posted a net income of $3,994,400 and $692,200, or $0.34 and $0.06 earnings per share, for the three and nine-month periods ended September 30, 2025, respectively, compared to net losses of $1,180,100 and $4,515,400, or $(0.11) and $(0.43) loss per share, for the three and nine-month periods ended September 30, 2024, respectively.

Scientific Industries will conduct a conference call to discuss financial results for the third quarter of 2025 on Thursday, November 20, 2025, at 11:00 A.M. ET. Interested parties can access the conference call by dialing (844) 481-2706 or (412) 317-0662 (international).

A replay of the call will be available through November 27, 2025, at (855) 669-9658 or (412) 317-0088 (international), replay access code: 4098504, or for 30 days at https://www.scientificindustries.com/investor-relations/.

Helena R. Santos or Joe Dorame can be reached for further information at 631-567-4700, or 602-889-9700, respectively, or via email at hsantos@scientificindustries.com, or SCND@lythampartners.com, respectively.

Source: Scientific Industries, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.